NCKAP5L Activators
Chemical activators of NCKAP5L operate through various mechanisms to modulate the protein's activity, primarily through the regulation of its phosphorylation state. Phorbol 12-myristate 13-acetate (PMA) directly stimulates protein kinase C (PKC), a key player in phosphorylating numerous proteins, including those associated with the cytoskeleton. The activation of PKC by PMA can lead to the targeted phosphorylation of NCKAP5L, which is essential for its role in organizing the cytoskeleton. Similarly, Bryostatin 1 influences PKC, albeit through a different binding mechanism, which can also result in the phosphorylation and therefore the activation of NCKAP5L. Calyculin A and Okadaic Acid both inhibit protein phosphatases PP1 and PP2A, enzymes responsible for dephosphorylating proteins. The inhibition of these phosphatases prevents the dephosphorylation of NCKAP5L, maintaining it in an active state.
Further, Forskolin and Dibutyryl-cAMP (db-cAMP) elevate intracellular cAMP levels, subsequently activating protein kinase A (PKA), which is known to phosphorylate a multitude of proteins. The activation of PKA can promote the phosphorylation and activation of NCKAP5L. Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent protein kinases, which may also phosphorylate and activate NCKAP5L. Anisomycin activates stress-activated protein kinases such as JNK and p38 MAP kinase, which are implicated in the phosphorylation of proteins involved in cytoskeletal regulation, providing another route for the activation of NCKAP5L. Finally, Phosphatidylinositol 4,5-bisphosphate (PIP2) serves as a substrate for the production of second messengers, leading to PKC activation and its associated phosphorylation pathways that include proteins like NCKAP5L. Each of these chemicals, through their unique interactions with cellular signaling pathways, can contribute to the regulation and activation of NCKAP5L, impacting its function within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a myriad of proteins. Given that NCKAP5L is a cytoskeletal protein, its activation is likely contingent on phosphorylation events. By activating PKC, PMA would promote phosphorylation cascades that could lead to the functional activation of NCKAP5L, enhancing its role in cytoskeletal rearrangement. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). By inhibiting these phosphatases, Calyculin A leads to an increase in the phosphorylation state of proteins within the cell. NCKAP5L, if it is regulated by phosphorylation, would remain in an activated state due to reduced dephosphorylation, thus enhancing its activity in the cell. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases like calmodulin kinase. These kinases could phosphorylate NCKAP5L, thereby functionally activating it as part of the signal transduction involved in cytoskeletal organization and cellular motility. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid functions as an inhibitor of PP1 and PP2A, like Calyculin A. This would act to maintain proteins in a phosphorylated state by preventing their dephosphorylation. If NCKAP5L activity is regulated by its phosphorylation status, the inhibition of these phosphatases by Okadaic Acid could lead to the sustained activation of NCKAP5L. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA, leading to phosphorylation of various target proteins. NCKAP5L, as part of the cellular cytoskeleton, could be activated by such PKA-mediated phosphorylation events, resulting in changes to cytoskeletal dynamics. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases such as JNK and p38 MAP kinase. These kinases can phosphorylate various substrates involved in cytoskeletal dynamics. Through the activation of these kinases, Anisomycin could contribute to the activation of NCKAP5L, facilitating its role in the cytoskeleton. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and modulates PKC activity, which is involved in the regulation of numerous proteins via phosphorylation. This modulation could result in the activation of NCKAP5L if it is a substrate for PKC-mediated phosphorylation, impacting cytoskeletal organization. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can lead to the activation of signaling pathways that regulate cytoskeletal dynamics. Through these pathways, Jasplakinolide could indirectly cause the activation of NCKAP5L, leading to its participation in actin filament organization. | ||||||